EE46 Venetoclax in Combination with Azacitidine Is Cost-Effective Vs. AZA for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Perspective
| Autor: | Guinan, K, Mathurin, K, Au, Y, Schuh, AC, Bui, CN, Chai, X, Lachaine, J |
|---|---|
| Zdroj: | In Value in Health July 2022 25(7) Supplement:S344-S344 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect